Our study introduces the dysregulation of the anti-fibrotic pathway i.e., JAK/STAT pathway as a possible scenario for CMV-mediated increased severity of liver fibrosis in HCV infection. The gene discussed is SOAT1; the disease is Hepatic fibrosis.